An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis

NCT04520308 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis
AD
Eczema

Interventions

DRUG: Dupilumab Only Product

Sponsor

Eric Simpson

Collaborators

[object Object]